MedPath

Evaluation of glucagon secretion in type 2 diabetes

Not Applicable
Completed
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000033387
Lead Sponsor
agasaki University Hospital
Brief Summary

The levels of plasma glucagon were elevated and peaked 30 min after the mixed meal ingestion in both type 1 diabetes and type 2 diabetes patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Exclusion Criteria

Patients uncontrolled fasting glucose at 80-180 mg/dL. Patients with cerebrovascular disease and/or cardiovascular disease. Pregnant women. Lactating women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of glucagon secretion when administered diet
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath